UnknownPHASE2, PHASE3NCT02858570

Conjugate Vaccine Against Meningococcus C a Brazilian Project

Studying Meningococcal meningitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Principal Investigator
Tatiana de Noronha, Doc
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Intervention
MenCC-BIO Vaccine(biological)
Enrollment
1644 target
Eligibility
19 years · All sexes
Timeline
2018 – 2020

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02858570 on ClinicalTrials.gov

Other trials for Meningococcal meningitis

Additional recruiting or active studies for the same condition.

See all trials for Meningococcal meningitis →

← Back to all trials